Nivolumab,Ipilimumab,Cabozantinib,Sunitinib,pembrolizumab
BMS,Pfizer,merck
['nivolumab', 'pembro', 'atezo', 'ipi/', 'key,note,45', 'key,note,361', 'rcc,(-irccs),(-srcc),(-urcc)', 'cabozantinib', 'thanks', 'key,note,564', 'check,mate,9er', 'check,mate,025', 'cabo ', 'nivo']
thanks for the opportunity! best of journals in medical oncology for rcc #kidneycancer triple therapy in mrcc tki &amp; io cabo+nivo one of the highest responses in non-clear cell pembro continues to have dfs. atezolizumab &amp; ipi/nivo no dfs or os 
Medical Oncology | Urologic Oncology @incmnszmx IDEA Award | Global Oncology TF @ASCO| Editorial fellow @JCOGO_ASCO #oncofertility @oncofertilty LATAM  @UPMex